Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Free Cash Flow: 2019-2025

Historic Free Cash Flow for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$8.9 million.

  • Biodesix's Free Cash Flow rose 18.12% to -$8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 53.13%. This contributed to the annual value of -$51.9 million for FY2024, which is 13.30% down from last year.
  • Biodesix's Free Cash Flow amounted to -$8.9 million in Q3 2025, which was down 34.87% from -$6.6 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Free Cash Flow registered a high of $809,000 during Q2 2021, and its lowest value of -$20.5 million during Q2 2024.
  • In the last 3 years, Biodesix's Free Cash Flow had a median value of -$9.7 million in 2023 and averaged -$11.1 million.
  • Per our database at Business Quant, Biodesix's Free Cash Flow surged by 118.23% in 2021 and then slumped by 1,326.58% in 2022.
  • Quarterly analysis of 5 years shows Biodesix's Free Cash Flow stood at -$10.7 million in 2021, then fell by 29.37% to -$13.9 million in 2022, then fell by 10.01% to -$15.3 million in 2023, then soared by 67.68% to -$4.9 million in 2024, then rose by 18.12% to -$8.9 million in 2025.
  • Its last three reported values are -$8.9 million in Q3 2025, -$6.6 million for Q2 2025, and -$8.7 million during Q1 2025.